A new under‑the‑skin version of isatuximab is now approved, giving multiple myeloma patients a much faster and more ...

People living with relapsed or refractory multiple myeloma now have a faster way to receive one of their key treatments. The ...

A UAB-led study finds that multiple myeloma returning within three years of intensive frontline treatment should be ...

Darzalex (daratumumab) is a biologic medication used to treat a type of blood cancer called multiple myeloma in adults. Doctors use it for people who have just been diagnosed, as well as for patients ...

Add Yahoo as a preferred source to see more of our stories on Google. A micrograph of myeloma neoplasm in a bone marrow biopsy. Johnson & Johnson’s Tecvayli helped people with multiple myeloma live ...

Dr. Robert Orlowski says a single-drug option in newly diagnosed myeloma may offer strong responses with fewer side effects and preserve future treatments. Dr. Robert Orlowski presented updated ELARA ...

Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...

For patients with newly diagnosed multiple myeloma not undergoing an autologous stem cell transplant, indefinite lenalidomide ...

New research from VCU Massey Comprehensive Cancer Center provides evidence for a combination treatment strategy that uses ...

When multiple myeloma returns after a period of remission, treatment plans often need to be adjusted because the cancer may have become resistant to previous medications. Doctors determine the most ...

Commonly prescribed cardiovascular medications - such as statins, diuretics, and blood pressure drugs - appear to have little or no negative impact on survival among people living with multiple ...